EarlySense VP to Speak at Connected Health Summit in San Diego
WOBURN, MA – August 26, 2019 – EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, today publicized that Ori Balaban, VP of Business Development, will be speaking at the Parks Associates’ sixth-annual Connected Health Summit: Independent Living and Wellness, taking place at the Pendry San Diego Hotel in San Diego, CA on August 27 – 29, 2019.
Balaban will participate in a panel — Innovation at Transformative Life Stages: New Parents and Caregivers — in which he will discuss how companies identify, engage, and form lasting relationships with individuals undergoing life transitions, and offer innovative solutions that provide true value at these transition moments. The session will take place on Tuesday August 27, 2019 at 4:00 pm.
“Transitional care technology is becoming more and more relevant as patients are living longer and becoming more dependent on supporting care technologies. I am proud to represent continuous monitoring solutions, instrumental within the post-acute health market, predicting and notifying the caregiver of elderly patient falls, possibility of bed sores and also monitoring key patient vitals,” said Balaban. “We are excited to be part of the global discussion and to share our insight with the wider medical technology and healthcare communities.”
EarlySense develops a contact-free continuous monitoring (CFCM) sensor that accurately and continuously monitors heart rate, respiratory rate and movement without ever touching the patient. The company’s CFCM technology has been successfully implemented in hospitals, nursing homes and rehab facilities around the world to assist health teams in early detection of patient deterioration, helping to prevent adverse events, including code blues which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls and pressure ulcers.
# # #
EarlySense® is the global leader in contact-free, continuous monitoring solutions for the healthcare continuum. Used worldwide in hospitals, post-acute care facilities, and homes, EarlySense assists clinicians in early detection of patient deterioration. The solution has been proven to help prevent adverse events, including code blue events which are a result of cardiac or respiratory arrest, preventable ICU transfers, patient falls, pressure ulcers, and hospital readmissions. EarlySense’s FDA-cleared solutions leverage big data analytics to provide actionable health insights and improve clinical outcomes. The company has partnered with leading global technology companies including Hill-Rom, Philips, Welch Allyn, Mitsui and Beurer. EarlySense is based in Ramat Gan, Israel, and Woburn, Massachusetts.
For more information, visit www.earlysense.com.